Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-041644
Filing Date
2008-02-28
Accepted
2008-02-28 15:32:31
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1182617
2 FORM OF CHANGE OF CONTROL AGREEMENT dex1010.htm EX-10.10 45718
3 AMENDED AND RESTATED BULK SUPPLY AGREEMENT dex1038.htm EX-10.38 171032
4 LIST OF SUBSIDIARIES dex21.htm EX-21 1846
5 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2963
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9304
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9295
8 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 3978
  Complete submission text file 0001193125-08-041644.txt   1428123
Mailing Address 397 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 397 EAGLEVIEW BLVD EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 08650304
SIC: 2834 Pharmaceutical Preparations